NCT07617571

Brief Summary

Background: Orthodontic forces induce tissue reactions by triggering perturbations from orthodontic appliances, which lead to the modelling and remodelling of alveolar bone. Despite the growing popularity of 3D-printed aligners, no studies have compared their effects on bone metabolism in comparison with thermoformed aligners. Aim: This study aims to assess bone metabolism in patients undergoing treatment with 3D-printed aligners versus thermoformed aligners.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Completed
Last Updated

June 1, 2026

Status Verified

May 1, 2026

Enrollment Period

29 days

First QC Date

May 24, 2026

Last Update Submit

May 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in levels of Osteoprotegerin (OPG)

    The frozen samples of GCF from participants with both types of aligners will be thawed at room temperature for enzyme-linked immunosorbent assay (ELISA).

    up to 21 days

Secondary Outcomes (3)

  • change in gingival inflammation

    up to 21 days

  • change in plaque accumulation

    up to 21 days

  • change in bleeding on probing

    up to 21 days

Study Arms (2)

directly printed aligners

EXPERIMENTAL
Other: Directly printed aligners using Tera Harz TA28 resin

thermoformed aligners

ACTIVE COMPARATOR
Other: PETG thermoplastic sheets

Interventions

Aligners will be digitally designed using the latest version of ArchForm software for segmentation of dental arches, virtual tooth movement planning and generation of sequential treatment stages, the finalized setups will be exported as STL files.

directly printed aligners

Aligners were digitally designed using the latest version of ArchForm software .The 3D-printed resin models which were used as a mold for aligner thermoforming, were fabricated by Anycubic Photon Mono M5s (12K resolution) (Anycubic, China) 3D printing machine.

thermoformed aligners

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Minor malocclusion (2 to 4 mm of crowding) .
  • Patients in need for Antero-posterior expansion and labial tipping of incisors without interproximal reduction
  • No use of anti-inflammatory drugs or antibiotics in the past 6 months.
  • Periodontal parameters of gingival index \<1 and no pocketing with a generalized pocketing depth of \<3mm.
  • Radiographic parameters of no crestal bone loss.
  • No history of smoking.

You may not qualify if:

  • Signs of inflammation of the gingiva, and periodontitis.
  • Systemic conditions (kidney disease, HIV, and liver disease).
  • Teeth missing or poor oral hygiene.
  • Bone disease e.g.; osteoporosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, Egypt

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The patients will be blinded at appliance delivery, to reduce the risk of bias. Moreover, the biologist in the laboratory who will do the measurements, and the statistician will be blinded to the nature of the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2026

First Posted

June 1, 2026

Study Start

June 1, 2026

Primary Completion

June 30, 2026

Study Completion

July 1, 2026

Last Updated

June 1, 2026

Record last verified: 2026-05

Locations